Business Context and Reporting Period
This Form 8-K is filed by Anthem, Inc. (now Elevance Health, Inc.) for the reporting period of January 7, 2002. The filing serves as a Regulation FD disclosure regarding upcoming meetings between company officers and securities analysts/investors scheduled for the week of January 7, 2002.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document references a press release from November 14, 2001, which contained earnings expectations, but does not restate those specific financial figures within this report.
Material Changes
No material changes to financial results or operations are reported in this document. The filing confirms the company's intent to reaffirm previously issued earnings expectations during upcoming investor meetings.
Guidance, Outlook, and Risks
Outlook: Management expects to confirm the ability to meet earnings expectations previously communicated on November 14, 2001.
Risks and Uncertainties: The filing explicitly lists factors that could cause actual results to differ materially from forward-looking statements, including:
- Trends in health care costs and utilization rates.
- Ability to secure sufficient premium rate increases.
- Competitor pricing below market trends of increasing costs.
- Increased government regulation of health benefits and managed care.
- Significant acquisitions or divestitures by major competitors.
- Introduction and utilization of new prescription drugs and technology.
- Potential downgrade in financial strength ratings.
- Litigation targeted at health benefits companies.
- Ability to contract with providers consistent with past practice.
- General economic downturns.
Investor Verification Checklist
- Verify the specific earnings expectations detailed in the November 14, 2001 press release (filed as Exhibit 99 to the prior 8-K).
- Review the final Prospectus dated October 29, 2001, for the initial public offering.
- Examine periodic reports (Form 10-K, 10-Q, and 8-K) for detailed financial data and risk disclosures.
- Monitor upcoming analyst meetings for any updates to the forward-looking statements made in this filing.